Log-In
|
Home
|
E-mail Alerts
|
My Headlines
|
Portfolio
Upgrade to StreetInsider Premium - FREE TRIAL!
Join Free
SI Premium
Full Feed View
Headline View
Upgrade to SI Premium
Ratings Insider
Analyst Comments
Hot Analyst Comments $
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Credit Ratings
Downgrade News
Hot Downgrades $
New Coverage News
Hot New Coverage $
Upgrade News
Hot Upgrades $
More...
M&A Insider
Merger News
Hot M&A News $
Private Equity
Rumors $
Merger Arbitrage
2012's Top M&A Deals
Top 50 Takeover Targets
More...
EPS Insider
Earnings Calendar
Earnings News
Hot Earnings $
Guidance
Hot Guidance $
Conference Calls
Earnings History Search
More...
Dividend Insider
Dividend News
Special Dividends $
Stock Buybacks
Hot Stock Buybacks $
Stock Splits
More...
IPO Insider
IPO News
Recent IPOs
Upcoming IPOs
More...
Hedge Fund Insider
Hedge Funds News
More...
Partners
QUICK LINKS :
Upcoming Dividends
EPS Movers
Top Upgrades
Buffett's Stocks
*NEW SI App
Newsletters
Follow @Street_Insider
More on ACOR
- Summary
- Chart
- Profile
- Historical
Data
- Earnings
- Ratings
- Holders
Financials
Income Statement
Balance Sheet
Cash Flow Statement
News
- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...
- 13Ds
- 13Fs
- 13Gs
- Analyst Comments
- Analyst EPS Change
- Analyst EPS View
- Analyst PT Change
- Commodities
- Conference Calls
- Contributors
- Corporate News
- Credit Ratings
- Dividends
- Downgrades
- Earnings
- Economic Data
- Equity Offerings
- ETFs
- FDA
- Fed
- Forex
- General News
- Hedge Funds
- Hot Buybacks
- Hot Comments
- Hot Corp. News
- Hot Dividends
- Hot Downgrades
- Hot Earnings
- Hot FDA News
- Hot Guidance
- Hot Hedge Fund News
- Hot Insider Trades
- Hot IPOs
- Hot List
- Hot M&A
- Hot Mgmt Changes
- Hot New Coverage
- Hot Upgrades
- Insiders' Blog
- IPOs
- Life Enjoyed
- Litigation
- Management Comments
- Market Check
- Momentum Movers
- New Coverage
- Option EPS Action
- Options
- Press Releases
- Private Equity
- SEC Filings
- Special Dividends
- Special Reports
- Stock Splits
- Technicals
- Trader Talk
- Trading Halts
- Upgrades
Acorda Therapeutics, Inc. (NQ:ACOR)
Delayed:
32.08
-0.32 (0.99%)
Trade Now!
Previous Close
$32.40
52 Week High
$40.87
Open
$32.40
52 Week Low
$21.26
Day High
$32.94
P/E
8.89
Day Low
$31.64
EPS
$3.61
Volume
3,650
Friends, Peers and Foes
(?)
:
PETM
,
SUN
,
MYL
CAB
(more...)
ALERTS
|
RSS
All Recent
SI Reports
Press Releases
SEC Filings
Major News
May 21, 2013 08:37 AM
Form 8-K ACORDA THERAPEUTICS INC For: May 21
May 21, 2013 08:10 AM
Acorda Therapeutics Announces Publication of New Data on Impact of Mobility Impairment Due to Multiple Sclerosis
May 20, 2013 07:34 AM
Form 8-K ACORDA THERAPEUTICS INC For: May 20
May 20, 2013 07:00 AM
Acorda Therapeutics Announces Issuance of Additional U.S. Patent for AMPYRA® Covering a Range of Dosage Strengths
May 17, 2013 07:00 AM
Acorda Therapeutics’ Legal Department Recognized on Best Legal Departments List by Corporate Counsel Magazine
May 15, 2013 07:00 AM
Acorda Therapeutics to Present at the UBS Global Healthcare Conference
May 10, 2013 04:03 PM
Form 4 ACORDA THERAPEUTICS INC For: May 08 Filed by: PANEM SANDRA PHD
May 10, 2013 12:24 PM
Form SC 13G/A ACORDA THERAPEUTICS INC Filed by: FMR LLC
May 10, 2013 11:04 AM
Form 10-Q ACORDA THERAPEUTICS INC For: Mar 31
May 9, 2013 07:39 AM
Form 8-K ACORDA THERAPEUTICS INC For: May 09
View All Articles
Feb 13, 2013 06:58 AM
Acorda Therapeutics (ACOR) Tops Q4 EPS by 9c, Provides 2013 Outlook
Jan 7, 2013 06:07 AM
Acorda (ACOR) Guides Q4, FY12, FY13 AMPYRA XR Sales
Oct 31, 2012 06:08 AM
Acorda Therapeutics (ACOR) Tops Q3 EPS Views; Reaffirms AMPYRA Sales Outlook
Jul 31, 2012 06:52 AM
Acorda Therapeutics (ACOR) Tops Q2 EPS by 15c
May 3, 2012 06:58 AM
Acorda Therapeutics (ACOR) Tops Q1 EPS by 18c
Feb 16, 2012 06:51 AM
Acorda Therapeutics (ACOR) Beats Q4 EPS Expectations; Revs Heavy
Nov 4, 2011 06:14 AM
Acorda Therapeutics, Inc. (ACOR) Misses Q3 EPS Views; Reaffirms Outlook
Aug 1, 2011 06:50 AM
Acorda Therapeutics (ACOR) Tops Q2 EPS by 7c
View All Major News
May 2, 2013 01:12 PM
UPDATE: MKM Partners Downgrades Acorda Therapeutics, Inc. (ACOR) to Sell
May 1, 2013 05:47 PM
Trading Radar for 05/02: MGM Resorts (MGM), GM (GM), Kraft Foods (KRFT), athenahealth (ATHN) Report
Apr 15, 2013 01:52 PM
Notable 52-Week Highs and Lows of the Day 04/15: (PG) (GSK) (VZ) High; (ABX) (FCX) (PAAS) Low
Apr 15, 2013 09:19 AM
StreetInsider.com Pre-Open Movers 4/15: (S) (LIFE) (NFP) Higher; (SLW) (ABX) (CLWR) Lower (more...)
Apr 15, 2013 06:40 AM
Acorda Therapeutics (ACOR) Says AMPYRA Improved Walking for Post-Stroke Deficits Patients
Mar 20, 2013 07:04 AM
Acorda Therapeutics (ACOR) Updates on Diazepam Nasal Spray Phase 1
Feb 13, 2013 06:58 AM
Acorda Therapeutics (ACOR) Tops Q4 EPS by 9c, Provides 2013 Outlook
Feb 12, 2013 05:31 PM
Trading Radar for 02/13: Cisco (CSCO), NVIDIA (NVDA), Deere & Co. (DE), Liberty Global (LBTYA), Zillow (Z) Report
Jan 8, 2013 07:58 AM
MKM Partners Downgrades Acorda Therapeutics, Inc. (ACOR) to Neutral
Jan 7, 2013 06:07 AM
Acorda (ACOR) Guides Q4, FY12, FY13 AMPYRA XR Sales
View All Reports
May 21, 2013 08:10 AM
Acorda Therapeutics Announces Publication of New Data on Impact of Mobility Impairment Due to Multiple Sclerosis
May 20, 2013 07:00 AM
Acorda Therapeutics Announces Issuance of Additional U.S. Patent for AMPYRA® Covering a Range of Dosage Strengths
May 17, 2013 07:00 AM
Acorda Therapeutics’ Legal Department Recognized on Best Legal Departments List by Corporate Counsel Magazine
May 15, 2013 07:00 AM
Acorda Therapeutics to Present at the UBS Global Healthcare Conference
May 9, 2013 07:00 AM
Acorda Therapeutics to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
May 9, 2013 07:00 AM
Acorda Therapeutics Announces Data Showing Dalfampridine Improves Motor Function in Preclinical Model of Post-Stroke Deficits Published in Stroke
May 6, 2013 07:00 AM
Acorda Therapeutics Recognized as One of the Best Places to Work in New York State for Third Consecutive Year
May 2, 2013 06:00 AM
Acorda Therapeutics Reports First Quarter 2013 Financial Results
Apr 25, 2013 07:00 AM
Acorda Therapeutics to Host Conference Call to Discuss First Quarter 2013 Financial Results on May 2, 2013
Apr 23, 2013 07:00 AM
Mayo Clinic and Acorda Therapeutics Announce Initiation of Phase 1 Trial of Remyelinating Antibody in People with Multiple Sclerosis
View All Press Releases
May 21, 2013 08:37 AM
Form 8-K ACORDA THERAPEUTICS INC For: May 21
May 20, 2013 07:34 AM
Form 8-K ACORDA THERAPEUTICS INC For: May 20
May 10, 2013 04:03 PM
Form 4 ACORDA THERAPEUTICS INC For: May 08 Filed by: PANEM SANDRA PHD
May 10, 2013 12:24 PM
Form SC 13G/A ACORDA THERAPEUTICS INC Filed by: FMR LLC
May 10, 2013 11:04 AM
Form 10-Q ACORDA THERAPEUTICS INC For: Mar 31
May 9, 2013 07:39 AM
Form 8-K ACORDA THERAPEUTICS INC For: May 09
May 2, 2013 07:10 AM
Form 8-K ACORDA THERAPEUTICS INC For: May 02
Apr 23, 2013 07:16 AM
Form 8-K ACORDA THERAPEUTICS INC For: Apr 23
Apr 15, 2013 06:59 AM
Form 8-K ACORDA THERAPEUTICS INC For: Apr 15
View All Filings
Entities mentioned with
ACOR
Earnings
|
View Related Stories »
Robert W Baird
|
View Related Stories »
Citi
|
View Related Stories »
Trading Radar
|
View Related Stories »
JPMorgan
|
View Related Stories »
Bank of America
|
View Related Stories »
UBS
|
View Related Stories »
Piper Jaffray
|
View Related Stories »
Dividend
|
View Related Stories »
Morning Movers
|
View Related Stories »
Deutsche Bank
|
View Related Stories »
Standard & Poor's
|
View Related Stories »
Merriman Curhan Ford
|
View Related Stories »
Unusual 11 Mid-Day Movers
|
View Related Stories »
Merrill Lynch
|
View Related Stories »
Stifel Nicolaus
|
View Related Stories »
Jefferies & Co
|
View Related Stories »
13G
|
View Related Stories »
Chicago PMI
|
View Related Stories »
Bankruptcy
|
View Related Stories »
Credit Suisse
|
View Related Stories »
Hedge Funds
|
View Related Stories »
Personal Income/Spending
|
View Related Stories »
After-Hours Movers
|
View Related Stories »
Stock Buyback
|
View Related Stories »
Show More...
View All Entities